NM_017802.4:c.1245C>T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_017802.4(DNAAF5):​c.1245C>T​(p.Ala415Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00147 in 1,604,072 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0017 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 35 hom. )

Consequence

DNAAF5
NM_017802.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.14

Publications

3 publications found
Variant links:
Genes affected
DNAAF5 (HGNC:26013): (dynein axonemal assembly factor 5) The protein encoded by this gene is essential for the preassembly or stability of axonemal dynein arms, and is found only in organisms with motile cilia and flagella. Mutations in this gene are associated with primary ciliary dyskinesia-18, a disorder characterized by abnormalities of motile cilia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2013]
DNAAF5 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 18
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.1).
BP6
Variant 7-754809-C-T is Benign according to our data. Variant chr7-754809-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 241195.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.14 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00174 (265/152314) while in subpopulation AMR AF = 0.00137 (21/15298). AF 95% confidence interval is 0.000919. There are 2 homozygotes in GnomAd4. There are 125 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017802.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF5
NM_017802.4
MANE Select
c.1245C>Tp.Ala415Ala
synonymous
Exon 5 of 13NP_060272.3
DNAAF5
NR_075098.2
n.1205C>T
non_coding_transcript_exon
Exon 5 of 13

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF5
ENST00000297440.11
TSL:1 MANE Select
c.1245C>Tp.Ala415Ala
synonymous
Exon 5 of 13ENSP00000297440.6
DNAAF5
ENST00000440747.5
TSL:2
c.648C>Tp.Ala216Ala
synonymous
Exon 5 of 13ENSP00000403165.1
DNAAF5
ENST00000437419.5
TSL:5
c.561C>Tp.Ala187Ala
synonymous
Exon 4 of 5ENSP00000410788.1

Frequencies

GnomAD3 genomes
AF:
0.00174
AC:
265
AN:
152196
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.0533
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00276
AC:
666
AN:
241656
AF XY:
0.00268
show subpopulations
Gnomad AFR exome
AF:
0.000836
Gnomad AMR exome
AF:
0.00230
Gnomad ASJ exome
AF:
0.0483
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000802
Gnomad OTH exome
AF:
0.00354
GnomAD4 exome
AF:
0.00145
AC:
2099
AN:
1451758
Hom.:
35
Cov.:
32
AF XY:
0.00148
AC XY:
1068
AN XY:
720520
show subpopulations
African (AFR)
AF:
0.000931
AC:
31
AN:
33314
American (AMR)
AF:
0.00244
AC:
108
AN:
44292
Ashkenazi Jewish (ASJ)
AF:
0.0499
AC:
1291
AN:
25888
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39414
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52276
Middle Eastern (MID)
AF:
0.000178
AC:
1
AN:
5622
European-Non Finnish (NFE)
AF:
0.000382
AC:
422
AN:
1105212
Other (OTH)
AF:
0.00410
AC:
246
AN:
59930
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
102
204
306
408
510
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00174
AC:
265
AN:
152314
Hom.:
2
Cov.:
32
AF XY:
0.00168
AC XY:
125
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41574
American (AMR)
AF:
0.00137
AC:
21
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0533
AC:
185
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000323
AC:
22
AN:
68036
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00475
Hom.:
3
Bravo
AF:
0.00201

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Sep 28, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Aug 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DNAAF5: BP4, BP7

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.94
DANN
Benign
0.69
PhyloP100
-3.1
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146922072; hg19: chr7-794446; COSMIC: COSV52418540; COSMIC: COSV52418540; API